Ireland
--:--IST
Latest
Clinical Trials in Norway / NCT04870151
Active, not recruiting Not applicable

Anterolateral Versus Direct Lateral Approach in Hemiarthroplasty for Hip Fracture

NCT04870151 · tracked via the Priya Life Science Norway tracker
Phase
Not applicable
Started
2021-06-01
Last updated
2025-05-14

Condition(s) studied

Hip Fractures

Investigational drug(s) / intervention(s)

Anterolateral approachDirect lateral approach

Anterolateral approach: Cemented hemiarthroplasty using an anterolateral approach.

Direct lateral approach: Cemented hemiarthroplasty using a direct lateral approach.

Study summary

Patients with dislocated hip fractures are randomised to cemented hemiarthroplasty with an anterolateral approach or a direct lateral approach.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * dislocated hip fracture. * planned cemented hemiarthroplasty. * able to walk, with or without walking aids, prior to the injury. Exclusion Criteria: * young and healthy patients with displaced hip fractures who are recommended total hip arthroplasty or open reduction / internal fixation of the fracture. * patients with severe comorbidity and high risk of cement-related complications who are recommended uncemented hemiarthroplasty (some, but not all, patients with ASA (American Society of Anesthesiologists) grade 4). * not able to give informed consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Innlandet Hospital Trust Gjøvik Innlandet

More Sykehuset Innlandet HF trials in Norway

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04870151 on ClinicalTrials.gov ↗ ← All trials in Norway